Prestige Consumer Healthcare (NYSE:PBH) Announces Quarterly Earnings Results

Prestige Consumer Healthcare (NYSE:PBHGet Free Report) released its quarterly earnings results on Thursday. The company reported $1.06 EPS for the quarter, beating analysts’ consensus estimates of $1.04 by $0.02, Briefing.com reports. Prestige Consumer Healthcare had a negative net margin of 7.26% and a positive return on equity of 13.82%. The firm had revenue of $282.74 million during the quarter, compared to analyst estimates of $280.25 million. During the same period in the previous year, the business earned $1.04 EPS. The business’s revenue for the quarter was up 2.6% on a year-over-year basis. Prestige Consumer Healthcare updated its FY 2024 guidance to 4.330-4.330 EPS.

Prestige Consumer Healthcare Price Performance

NYSE:PBH traded down $0.54 during mid-day trading on Friday, reaching $68.26. The stock had a trading volume of 152,367 shares, compared to its average volume of 241,678. The stock has a market capitalization of $3.39 billion, a P/E ratio of -41.17, a P/E/G ratio of 1.82 and a beta of 0.50. Prestige Consumer Healthcare has a one year low of $55.96 and a one year high of $69.29. The firm has a 50 day moving average price of $60.71 and a two-hundred day moving average price of $60.17. The company has a debt-to-equity ratio of 0.82, a quick ratio of 1.75 and a current ratio of 2.99.

Institutional Investors Weigh In On Prestige Consumer Healthcare

Hedge funds have recently made changes to their positions in the business. Altshuler Shaham Ltd purchased a new position in Prestige Consumer Healthcare in the 4th quarter worth $27,000. Natixis bought a new position in shares of Prestige Consumer Healthcare during the fourth quarter valued at about $36,000. International Assets Investment Management LLC increased its holdings in shares of Prestige Consumer Healthcare by 1,900.0% in the fourth quarter. International Assets Investment Management LLC now owns 980 shares of the company’s stock worth $60,000 after buying an additional 931 shares during the period. Rockefeller Capital Management L.P. boosted its holdings in Prestige Consumer Healthcare by 86.8% during the 4th quarter. Rockefeller Capital Management L.P. now owns 1,128 shares of the company’s stock valued at $70,000 after acquiring an additional 524 shares during the period. Finally, Tower Research Capital LLC TRC boosted its holdings in Prestige Consumer Healthcare by 131.0% during the 3rd quarter. Tower Research Capital LLC TRC now owns 2,559 shares of the company’s stock valued at $146,000 after acquiring an additional 1,451 shares during the period. 99.95% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

A number of equities analysts have weighed in on the company. BMO Capital Markets decreased their target price on Prestige Consumer Healthcare from $124.00 to $117.00 and set an “outperform” rating on the stock in a research note on Wednesday, November 15th. Royal Bank of Canada dropped their target price on shares of Prestige Consumer Healthcare from $110.00 to $103.00 and set a “sector perform” rating for the company in a research report on Wednesday, November 15th. Finally, StockNews.com raised shares of Prestige Consumer Healthcare from a “hold” rating to a “buy” rating in a report on Thursday, February 1st. One equities research analyst has rated the stock with a hold rating and three have issued a buy rating to the stock. Based on data from MarketBeat, Prestige Consumer Healthcare presently has a consensus rating of “Moderate Buy” and an average target price of $97.00.

Check Out Our Latest Analysis on PBH

Prestige Consumer Healthcare Company Profile

(Get Free Report)

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.

Featured Articles

Earnings History for Prestige Consumer Healthcare (NYSE:PBH)

Receive News & Ratings for Prestige Consumer Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prestige Consumer Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.